BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26507166)

  • 1. HO-1 inhibits IL-13-induced goblet cell hyperplasia associated with CLCA1 suppression in normal human bronchial epithelial cells.
    Mishina K; Shinkai M; Shimokawaji T; Nagashima A; Hashimoto Y; Inoue Y; Inayama Y; Rubin BK; Ishigatsubo Y; Kaneko T
    Int Immunopharmacol; 2015 Dec; 29(2):448-453. PubMed ID: 26507166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin Suppresses Chloride Channel Accessory 1 and Inhibits Interleukin-13-Induced Goblet Cell Hyperplasia in Human Bronchial Epithelial Cells.
    Nagashima A; Shinkai M; Shinoda M; Shimokawaji T; Kimura Y; Mishina K; Sato T; Toda M; Inayama Y; Rubin BK; Kaneko T
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6585-6590. PubMed ID: 27550358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solithromycin inhibits IL-13-induced goblet cell hyperplasia and MUC5AC, CLCA1, and ANO1 in human bronchial epithelial cells.
    Kimura Y; Shinoda M; Shinkai M; Kaneko T
    PeerJ; 2023; 11():e14695. PubMed ID: 36684665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells.
    Tanabe T; Kanoh S; Tsushima K; Yamazaki Y; Kubo K; Rubin BK
    Am J Respir Cell Mol Biol; 2011 Nov; 45(5):1075-83. PubMed ID: 21642590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiotropium attenuates IL-13-induced goblet cell metaplasia of human airway epithelial cells.
    Kistemaker LE; Hiemstra PS; Bos IS; Bouwman S; van den Berge M; Hylkema MN; Meurs H; Kerstjens HA; Gosens R
    Thorax; 2015 Jul; 70(7):668-76. PubMed ID: 25995156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-13-induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells.
    Kanoh S; Tanabe T; Rubin BK
    Clin Exp Allergy; 2011 Dec; 41(12):1747-56. PubMed ID: 22092504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-13 induces mucin 5AC production involving STAT6/SPDEF in human airway epithelial cells.
    Yu H; Li Q; Kolosov VP; Perelman JM; Zhou X
    Cell Commun Adhes; 2010 Aug; 17(4-6):83-92. PubMed ID: 21275604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between calcium-activated chloride channel 1 and MUC5AC in goblet cell hyperplasia induced by interleukin-13 in human bronchial epithelial cells.
    Yasuo M; Fujimoto K; Tanabe T; Yaegashi H; Tsushima K; Takasuna K; Koike T; Yamaya M; Nikaido T
    Respiration; 2006; 73(3):347-59. PubMed ID: 16465045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niflumic acid suppresses interleukin-13-induced asthma phenotypes.
    Nakano T; Inoue H; Fukuyama S; Matsumoto K; Matsumura M; Tsuda M; Matsumoto T; Aizawa H; Nakanishi Y
    Am J Respir Crit Care Med; 2006 Jun; 173(11):1216-21. PubMed ID: 16528019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating prostaglandin E2 receptor subtype EP4 increases secreted mucin from airway goblet cells.
    Akaba T; Komiya K; Suzaki I; Kozaki Y; Tamaoki J; Rubin BK
    Pulm Pharmacol Ther; 2018 Feb; 48():117-123. PubMed ID: 29129801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic IL9 and IL-13 exposure leads to an altered differentiation of ciliated cells in a well-differentiated paediatric bronchial epithelial cell model.
    Parker JC; Thavagnanam S; Skibinski G; Lyons J; Bell J; Heaney LG; Shields MD
    PLoS One; 2013; 8(5):e61023. PubMed ID: 23671562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IL-13-induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC.
    Suzaki I; Kawano S; Komiya K; Tanabe T; Akaba T; Asano K; Suzaki H; Izuhara K; Rubin BK
    Respirology; 2017 Jan; 22(1):93-100. PubMed ID: 27553766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid and long-acting ß-agonist therapy reduces epithelial goblet cell metaplasia.
    Lachowicz-Scroggins ME; Finkbeiner WE; Gordon ED; Yuan S; Zlock L; Bhakta NR; Woodruff PG; Fahy JV; Boushey HA
    Clin Exp Allergy; 2017 Dec; 47(12):1534-1545. PubMed ID: 28833774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of mucus production by interleukin-13 receptor alpha2 in the human airway epithelium.
    Tanabe T; Fujimoto K; Yasuo M; Tsushima K; Yoshida K; Ise H; Yamaya M
    Clin Exp Allergy; 2008 Jan; 38(1):122-34. PubMed ID: 18028464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-13 stimulates MUC5AC expression via a STAT6-TMEM16A-ERK1/2 pathway in human airway epithelial cells.
    Qin Y; Jiang Y; Sheikh AS; Shen S; Liu J; Jiang D
    Int Immunopharmacol; 2016 Nov; 40():106-114. PubMed ID: 27588910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of MMP/ADAM inhibitors on goblet cell hyperplasia in cultured human bronchial epithelial cells.
    Yoshisue H; Hasegawa K
    Biosci Biotechnol Biochem; 2004 Oct; 68(10):2024-31. PubMed ID: 15502346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant DNA methylation and expression of SPDEF and FOXA2 in airway epithelium of patients with COPD.
    Song J; Heijink IH; Kistemaker LEM; Reinders-Luinge M; Kooistra W; Noordhoek JA; Gosens R; Brandsma CA; Timens W; Hiemstra PS; Rots MG; Hylkema MN
    Clin Epigenetics; 2017; 9():42. PubMed ID: 28450970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin differentially affects the IL-13-induced expression profile in human bronchial epithelial cells.
    Mertens TC; Hiemstra PS; Taube C
    Pulm Pharmacol Ther; 2016 Aug; 39():14-20. PubMed ID: 27246785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of SAM-pointed domain-containing Ets-like factor in chronic rhinosinusitis with nasal polyps.
    Bai J; Miao B; Wu X; Luo X; Ma R; Zhang J; Li L; Shi J; Li H
    Laryngoscope; 2015 Mar; 125(3):E97-103. PubMed ID: 25376946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seihaito, a Kampo medicine, attenuates IL-13-induced mucus production and goblet cell metaplasia.
    Sekiya T; Murakami K; Isohama Y
    J Pharmacol Sci; 2024 Jun; 155(2):21-28. PubMed ID: 38677782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.